Mia's Feed
Medical News & Research

When Parental DNA Discrepancies Occur, Embryos Have Self-Correcting Mechanisms

When Parental DNA Discrepancies Occur, Embryos Have Self-Correcting Mechanisms

Share this article

New research reveals how embryos repair mismatches in parental DNA, ensuring proper chromosome segregation and healthy development. This self-correction mechanism may pave the way for innovative fertility therapies.

2 min read

Successful embryo development depends on complex genetic processes, especially when a sperm fertilizes an egg. One essential step involves reorganizing the parental DNA to create a unified genome, which is crucial before the embryo divides for the first time. Scientists have long recognized that sperm and eggs package their DNA differently, with an assumption that the key regions known as centromeres—responsible for pulling chromosomes apart during cell division—are uniform across maternal and paternal chromosomes. These centromeres are marked by the protein CENPA, which acts as a molecular tag, maintaining their identity through successive cell divisions and generations.

Traditionally, it was believed that maternal and paternal centromeres were similar because they both contained CENPA. However, new research from the University of Michigan challenges this assumption. The team found that sperm cells only deposit a fraction of CENPA compared to the egg, leading to an imbalance in centromere strength between the two sets of chromosomes.

This imbalance could threaten proper chromosome segregation during cell division, potentially resulting in errors like aneuploidy, which causes developmental disorders such as Down syndrome and increases the risk of miscarriage. The question then arises: how does the embryo correct this disparity?

Researchers tracked CENPA levels in maternal and paternal chromosomes during fertilization in mice. They observed that a second protein, CENPC, accumulates preferentially on the father's chromosomes and recruits additional CENPA from the egg's cytoplasm to equalize chromosomal centromere strength before the first cell division. This process appears to be a vital correction mechanism to ensure accurate chromosome segregation.

Interestingly, this phenomenon is not limited to mice; similar CENPA level variations are evident in human embryos. Moreover, CENPA levels vary significantly across individual eggs and individuals, possibly explaining why some embryos develop normally while others encounter developmental issues. The findings open opportunities for future therapies, especially for cases where eggs may have insufficient CENPA levels, potentially preventing chromosomal errors from the outset.

Overall, this study highlights the embryo's remarkable ability to self-correct genetic imbalances, ensuring healthy development despite parental DNA discrepancies.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Innovative AI Enhances Women's Heart Risk Assessment Using Routine Mammograms

A new AI-driven method uses routine mammogram images and age data to accurately predict women's cardiovascular disease risk, offering a cost-effective, dual-purpose screening tool.

Promising Results for Ifinatamab Deruxtecan in Treating Extensive-Stage Small Cell Lung Cancer

Clinical trials highlight the promising efficacy and safety of ifinatamab deruxtecan in treating extensive-stage small cell lung cancer, offering new hope for patients with limited options.

Innovative Cellular Therapy Transitioning from Cancer Treatment to Autoimmune Disease Management

A pioneering cellular therapy originally designed for cancer is now entering clinical trials to treat autoimmune diseases, offering hope for a potential cure with a single infusion. Sylvester Comprehensive Cancer Center is leading this innovative research that targets B cells involved in both conditions.